Government of the Gambia   Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
1982
NCT00294580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Medical Research Center, The Gambia

Active Ingredients

Drugs in Phase 4 Trials (1)

pyrimethamine (daraprim) (1 trial)

Drugs in Phase 2 Trials (2)

measles-rubella vaccine (M-R-Vax) (1 trial)

rubella virus vaccine live (Meruvax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Measles (Phase 2)

Rubella (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3